Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0SJ3W
|
|||
Former ID |
DNC011982
|
|||
Drug Name |
2-Furan-2-ylmethyl-1,2-dihydro-indazol-3-one
|
|||
Synonyms |
CHEMBL3144716; 1,2-dihydro-2-(2-furylmethyl)-3H-indazol-3-one; 120273-74-7; 2-Furan-2-ylmethyl-1,2-dihydro-indazol-3-one; CHEMBL268738; BDBM50009008; AKOS023543910
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C12H10N2O2
|
|||
Canonical SMILES |
C1=CC=C2C(=C1)C(=O)N(N2)CC3=CC=CO3
|
|||
InChI |
1S/C12H10N2O2/c15-12-10-5-1-2-6-11(10)13-14(12)8-9-4-3-7-16-9/h1-7,13H,8H2
|
|||
InChIKey |
FFYKZUMLEJLSIN-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Indazolinones, a new series of redox-active 5-lipoxygenase inhibitors with built-in selectivity and oral activity. J Med Chem. 1991 Mar;34(3):1028-36. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.